Cytox Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Out of Business

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Liquidation

Cytox General Information

Description

Developer of transformational prognostic technology designed to detect diseases early enough to make a difference. The company's technology helps in the assessment of developing dementias such as Alzheimer's disease as well as develops blood-based assays to aid in the development of new, effective dementia treatments, enabling patients to avail of treatment quickly, resulting in a quality medical outcome.

Contact Information

Website
www.cytoxgroup.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • John Eccles House, Robert Robinson Avenue
  • Oxford Science Park
  • Oxford OX4 4GP
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Other Healthcare Services
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • John Eccles House, Robert Robinson Avenue
  • Oxford Science Park
  • Oxford OX4 4GP
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytox Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Bankruptcy: Liquidation 04-Jan-2024 Completed Bankruptcy: Liquidation
17. Later Stage VC 23-Feb-2022 Completed Startup
16. Secondary Transaction - Private 01-Mar-2021 Completed Startup
15. Angel (individual) 03-Dec-2020 Completed Startup
14. Grant 01-Jun-2020 Completed Startup
13. Grant 01-Jan-2020 Completed Startup
12. Later Stage VC 08-Jul-2019 Completed Startup
11. Later Stage VC 04-Jul-2018 Completed Startup
10. Grant 07-Mar-2018 $1.11M $12.2M Completed Startup
9. Later Stage VC 30-Sep-2015 $1.01M $12.2M Completed Startup
To view Cytox’s complete valuation and funding history, request access »

Cytox Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
C1
C1
C Ordinary
C1
C Ordinary
C1
C Ordinary
C1
C Ordinary 832,778 $0.000135 $0.66 $0.66 1x $0.66 2.13%
C Ordinary 1,046,086 $0.000135 $0.78 $0.78 1x $0.78 2.67%
To view Cytox’s complete cap table history, request access »

Cytox Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of transformational prognostic technology designed to detect diseases early enough to make a difference. The c
Biotechnology
Oxford, United Kingdom
8 As of 2023

Dublin, Ireland
 

Hamburg, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cytox Competitors (8)

One of Cytox’s 8 competitors is Genuity Science, a Formerly VC-backed company based in Dublin, Ireland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genuity Science Formerly VC-backed Dublin, Ireland
Indivumed Therapeutics Private Debt Financed Hamburg, Germany
Igenomix USA Formerly PE-Backed Paterna, Spain
OmeCare Formerly VC-backed San Diego, CA
Ambry Genetics Formerly PE-Backed Aliso Viejo, CA
You’re viewing 5 of 8 competitors. Get the full list »

Cytox Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Cytox Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201510067-D0 Polymorphisms associated with alzheimer's disease Inactive 10-Jun-2015

Cytox Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Cytox FAQs

  • When was Cytox founded?

    Cytox was founded in 2004.

  • Where is Cytox headquartered?

    Cytox is headquartered in Oxford, United Kingdom.

  • What is the size of Cytox?

    Cytox has 8 total employees.

  • What industry is Cytox in?

    Cytox’s primary industry is Biotechnology.

  • Is Cytox a private or public company?

    Cytox is a Private company.

  • What is Cytox’s current revenue?

    The current revenue for Cytox is .

  • How much funding has Cytox raised over time?

    Cytox has raised $20.4M.

  • Who are Cytox’s competitors?

    Genuity Science, Indivumed Therapeutics, Igenomix USA, OmeCare, and Ambry Genetics are some of the 8 competitors of Cytox.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process